Mumbai, June 8 -- The inhaler is indicated for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD) in Spain.

The pressurised metered dose inhaler (pMDI) combines Lupin's respiratory expertise and manufacturing capabilities with ERN's established distribution network and customer relationships in the Spanish market.

The collaboration marks a step forward in expanding access to respiratory care solutions in Europe, leveraging Lupin's global inhalation portfolio and ERN's local market presence to strengthen patient reach in Spain.

Thierry Volle, President EMEA and Emerging Markets, Lupin said, "The launch of Luforbec in Spain, following successful introductions in the UK and Germany, represents a key milestone i...